CONMED (CNMD) PT Raised to $56 at Summer Street Post Q4

January 28, 2015 8:18 AM

Summer Street analyst Mark Landy reiterated a Buy rating and boosted his price target on CONMED (NASDAQ: CNMD) to $56.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found